V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300004299 | 300003019 | 1.47 | 73 | Palliative (P) | 2017-11-26 | 2017-11-26 | PEMBROLIZUMAB | 02 | N | 300023021 | DOCETAXEL |
| 300004300 | 300003019 | 1.79 | null | Palliative (P) | 2013-01-27 | 2013-02-01 | CARBOPLATIN + RT | N | N | 300023021 | COMPARE TRIAL |
| 300004301 | 300003019 | null | 105 | Palliative (P) | 2016-03-05 | 2016-03-05 | PACLITAXEL | 01 | N | 300023021 | CAPECITABINE + CISPLATIN |
| 300004302 | 300003019 | null | null | Adjuvant (A) | 2014-08-22 | 2014-09-01 | ESPAC-4 TRIAL | 01 | N | 300023021 | CAPECITABINE + GEMCITABINE |
| 300004303 | 300003020 | 1.59 | null | Neo-adjuvant (N) | 2014-05-19 | 2014-05-19 | ESPAC-4 TRIAL | N | N | 300023035 | FLUOROURACIL + MITOMYCIN + RT |
| 300004304 | 300003021 | 1.64 | 57.1 | Palliative (P) | null | 2014-09-21 | Carboplatin + Etoposide iv&po | null | null | 300023039 | GEMCARBO |
| 300004305 | 300003022 | null | 0 | Curative (C) | 2018-02-06 | 2018-02-21 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | N | N | 300023057 | GEMCARBO |
| 300004306 | 300003023 | 0 | 53.9 | Curative (C) | 2015-05-13 | 2015-05-25 | IMATINIB | 2 | Y | 300023061 | CISPLATIN + FLUOROURACIL + RT |
| 300004307 | 300003023 | 1.97 | 83 | Adjuvant (A) | 2016-06-20 | 2016-07-02 | Vinblastine weekly | N | N | 300023061 | FLUOROURACIL |
| 300004308 | 300003023 | null | 84 | Adjuvant (A) | 2016-09-27 | 2016-09-27 | GEMCARBO | N | N | 300023061 | FLUOROURACIL + MITOMYCIN + RT |
| 300004309 | 300003024 | 1.86 | null | Adjuvant (A) | 2014-04-20 | 2014-05-08 | CARBOPLATIN + RT | 02 | N | 300023075 | CAPECITABINE + GEMCITABINE |
| 300004310 | 300003025 | null | 73.8 | Adjuvant (A) | 2016-12-26 | 2017-01-08 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 300023081 | CARBOPLATIN + RT |
| 300004311 | 300003026 | null | 55 | Palliative (P) | 2013-12-31 | 2014-01-01 | Carboplatin + Etoposide iv&po | Y | null | 300023085 | CARBOPLATIN + ETOPOSIDE |
| 300004312 | 300003027 | 1.46 | 45.2 | Adjuvant (A) | 2018-01-13 | 2018-01-14 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 300023091 | ESPAC TRIAL |
| 300004313 | 300003028 | 1.6 | 69 | Curative (C) | 2016-08-04 | 2016-09-06 | CARBOPLATIN + ETOPOSIDE | N | Y | 300023095 | CISPLATIN + ETOPOSIDE |
| 300004314 | 300003029 | 1.86 | null | Curative (C) | 2017-11-20 | 2017-11-21 | CARBOPLATIN + RT | N | null | 300023096 | CAPECITABINE + CISPLATIN + RT |
| 300004315 | 300003030 | 1.61 | 75.4 | Curative (C) | 2014-05-20 | 2014-05-26 | null | N | N | 300023097 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300004317 | 300003032 | 1.74 | 77.8 | Adjuvant (A) | 2014-10-20 | 2014-10-20 | CARBOPLATIN + RT | N | N | 300023107 | COMPARE TRIAL |
| 300004318 | 300003032 | 1.58 | 67.6 | Neo-adjuvant (N) | 2016-07-03 | 2016-08-31 | Mitotane 2g | N | N | 300023107 | NOT MATCHED |
| 300004319 | 300003032 | 1.87 | 98.3 | Palliative (P) | 2016-06-23 | 2016-07-22 | Capecitabine + Cisplatin | N | N | 300023107 | CARBO + FLUOROURACIL |
| 300004320 | 300003032 | null | 51 | Palliative (P) | 2018-03-02 | 2018-03-02 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 01 | N | 300023107 | CAPECITABINE + CISPLATIN |
| 300004321 | 300003033 | 1.58 | 91.3 | Neo-adjuvant (N) | 2017-07-24 | 2017-08-10 | Cisplatin + Topotecan | N | N | 300023124 | FEC |
| 300004322 | 300003034 | 1.65 | 50.3 | Palliative (P) | 2014-08-04 | 2014-09-01 | FLUOROURACIL + MITOMYCIN | N | N | 300023127 | DOCETAXEL |
| 300004323 | 300003035 | 1.82 | null | null | 2014-07-06 | 2014-08-15 | Capecitabine (21days) + Carboplatin | 02 | N | 300023134 | CISPLATIN + DOCETAXEL |
| 300004324 | 300003035 | 1.66 | 44.4 | Not known (9) | 2017-07-31 | 2017-08-22 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 300023134 | GEMCARBO |
| 300004326 | 300003037 | 1.67 | 60.3 | Palliative (P) | 2013-12-16 | 2013-12-23 | CARBOPLATIN + ETOPOSIDE | 2 | N | 300023170 | CARBO + FLUOROURACIL |
| 300004328 | 300003039 | 1.61 | 88 | Adjuvant (A) | 2014-05-16 | 2014-05-29 | Gemcitabine + Capecitabine | 02 | N | 300023175 | IPILIMUMAB |
| 300004329 | 300003040 | 1.56 | 37.2 | Neo-adjuvant (N) | 2017-08-29 | 2017-09-04 | ACTICCA-1 Trial | 02 | null | 300023176 | PACLITAXEL |
| 300004330 | 300003041 | 0 | 99.1 | Adjuvant (A) | 2013-09-04 | 2013-09-19 | CARBOPLATIN + RT | N | N | 300023186 | CARBOPLATIN |
| 300004331 | 300003042 | 1.68 | 73 | Palliative (P) | 2014-11-05 | 2014-11-05 | GEMCARBO | 2 | N | 300023187 | CARBO + FLUOROURACIL |
| 300004332 | 300003043 | 1.72 | 92 | Curative (C) | 2013-02-15 | 2013-02-16 | Bevacizumab 7.5mg/kg | N | N | 300023188 | FEC + DOCETAXEL |
| 300004334 | 300003045 | 1.77 | 97 | Curative (C) | 2016-02-01 | 2016-02-22 | CARBOPLATIN + RT | 2 | Y | 300023215 | CARBOPLATIN + RT |
| 300004335 | 300003046 | null | null | Curative (C) | 2013-11-12 | 2013-11-12 | ESPAC-4 TRIAL | Y | null | 300023219 | CAPECITABINE + GEMCITABINE |
| 300004336 | 300003047 | 1.86 | null | Neo-adjuvant (N) | 2016-11-07 | 2016-11-07 | DE-ESCALATE TRIAL | 01 | N | 300023226 | BCG |
| 300004337 | 300003047 | 1.65 | 81.8 | null | 2015-05-26 | 2015-06-15 | Carboplatin + Etoposide iv&po | N | N | 300023226 | CARBOPLATIN + ETOPOSIDE |
| 300004338 | 300003048 | 1.88 | 86.7 | Curative (C) | 2014-12-04 | 2014-12-17 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | 300023251 | CARBOPLATIN |
| 300004339 | 300003049 | 1.94 | null | Palliative (P) | 2014-02-14 | 2014-02-20 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300023259 | CARBOPLATIN + ETOPOSIDE |
| 300004340 | 300003050 | 1.7 | 62 | Adjuvant (A) | 2014-04-17 | 2014-04-19 | Cisplatin + Fluorouracil + RT 5day | 1 | N | 300023265 | CISPLATIN + FLUOROURACIL + RT |
| 300004341 | 300003050 | 1.55 | null | Curative (C) | 2014-09-15 | 2014-09-18 | Carboplatin + Etoposide iv&po | 2 | null | 300023265 | NILOTINIB |
| 300004342 | 300003051 | 1.88 | null | Curative (C) | null | 2017-01-19 | Capecitabine + Oxaliplatin 21day | N | N | 300023278 | CARBOPLATIN |
| 300004343 | 300003052 | 1.54 | 60.7 | null | 2017-11-20 | 2017-11-20 | Folfirinox | 02 | null | 300023280 | IRINOTECAN + MDG |
| 300004344 | 300006103 | null | null | Curative (C) | 2017-11-19 | 2017-11-27 | GEMCARBO | 01 | N | 300023285 | GEMCARBO |
| 300004345 | 300006103 | null | 65 | Curative (C) | 2014-07-15 | 2014-08-08 | ESPAC-4 TRIAL | N | N | 300023285 | ESPAC TRIAL |
| 300004348 | 300003054 | 1.59 | 72.5 | Curative (C) | 2016-03-07 | 2016-03-13 | Fluorouracil+Mitomycin+RT (Anal Ca) | Y | Y | 300023299 | DE-ESCALATE TRIAL |
| 300004349 | 300003055 | 1.58 | 37.2 | Curative (C) | 2016-07-01 | 2016-07-25 | Carboplatin + Etoposide iv&po | Y | Y | 300023300 | FLUOROURACIL + MITOMYCIN + RT |
| 300004350 | 300003056 | 1.65 | 61.6 | Adjuvant (A) | 2015-12-23 | 2016-01-02 | ESPAC-4 TRIAL | 01 | null | 300023301 | CARBOPLATIN + RT |
| 300004351 | 300003056 | 1.83 | 61.7 | Curative (C) | 2017-12-30 | 2018-01-05 | Carbo F | 2 | N | 300023301 | GEMCARBO |
| 300004352 | 300003056 | 1.5 | 54.9 | Curative (C) | 2013-11-09 | 2013-11-20 | Rituximab (Maintenance) | 02 | N | 300023301 | PRICKLE TRIAL |
| 300004353 | 300003056 | 1.74 | null | Palliative (P) | 2015-01-14 | 2015-02-01 | FLUOROURACIL + OXALIPLATIN | 2 | N | 300023301 | COMPARE TRIAL |
| 300004354 | 300003057 | 0 | 84.4 | Palliative (P) | 2017-04-09 | 2017-04-10 | Capecitabine + Cisplatin | N | N | 300023310 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |